Pfizer

BSAC Spring Conference 2018 – Word from our Sponsor

Today, Pfizer UK offers patients access to a diverse portfolio of over 20 antibacterial and
antifungal medicines.

More than ever, the world needs new approaches to preventing and fighting infections.

Pfizer joined with over 100 industry partners to sign the Declaration on Combating Antimicrobial Resistance, announced in January 2016 at Davos, to call on governments to join industry in taking swift, coordinated action to help fight antimicrobial resistance.

Pfizer sponsors the most comprehensive global antimicrobial resistance surveillance program in the industry. These programmes provide critical data regarding antibiotic resistance patterns that enable physicians and healthcare providers to make the most appropriate treatment choices for their patients. The goals of these programmes are to provide important information on resistance and to assess antibiotic stewardship.

Pfizer routinely sponsors and conducts medical education outreach to healthcare providers through a variety of channels, including medical symposia, to ensure appropriate utilisation of antibiotics and improve infection prevention and control.

Pfizer is proud to sponsor the BSAC Spring Conference 2018 and we look forward to sharing our symposium with you.

PP-ZVA-GBR-0381

Date of preparation: February 2018